Download Files:
Inebilizumab
Price range: 251 CAD through 2,176 CAD
Products Details
Product Description
– Inebilizumab is a humanized anti-CD19 monoclonal antibody with enhanced antibody-dependent cell-mediated cytotoxicity against B cells. Inebilizumab can be used to treat a range of autoimmune diseases associated with CD19 B cells, such as multiple sclerosis and optic neuromyelitis.
Web ID
– T76713
Storage Temperature
– -20℃
Shipping
– Blue Ice
References
– Chen D, et al. Inebilizumab, a B Cell-Depleting Anti-CD19 Antibody for the Treatment of Autoimmune Neurological Diseases: Insights from Preclinical Studies. J Clin Med. 2016 Nov 24;5(12):107.
CAS Number
– 1299440-37-1
Molecular Weight
Compound Purity
– 99.1% (SDS-PAGE); 96.2% (SEC-HPLC)
Pathway
– Antibody-drug Conjugate/ADC Related
Product type
– Inhibitory Antibodies
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
